Press Releases on November 6, 2023 - EIN Presswire - Press Release Distribution Service

Published on November 6, 2023 - 21:05 GMT

Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance ...

Highlights: Third quarter testing volume grew 18% year-over-year, excluding contributions from the SneakPeek® Early Gender DNA Test, the fifth consecutive quarter of double-digit year-over-year growth. In the third quarter and year-to-date: Hereditary …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Consolidated Water Group Acquires Ramey Environmental Compliance, Broadening Presence in Water-Stressed Western U.S.

GEORGE TOWN, Cayman Islands and FOUNTAIN VALLEY, Calif. and DENVER, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, announced …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

SILVER SPRING, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its third quarter 2023 financial results after market close on Monday, …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

EverQuote Announces Third Quarter 2023 Financial Results

Third Quarter Revenue of $55.0 million Third Quarter Variable Marketing Margin of $19.4 million, Representing 35% of Revenue CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

BioAtla to Participate in the Jefferies London Healthcare Conference

SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Rover Reports Third Quarter 2023 Financial Results

Third quarter revenue increased to $66.2 million, up 30% year-over-year GAAP net income was $10.5 million compared to a GAAP net loss of $15.5 million in Q3 2022 Adjusted EBITDA was $17.5 million compared to $10.2 million in Q3 2022 Company raises full …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

RayzeBio to Participate in Upcoming Investor Conferences in November 2023

SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a biopharmaceutical company developing an innovative radiopharmaceutical pipeline to treat different cancers, today announced that members of the Company’s management team will …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 21:05 GMT

Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook

MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 ...

Q3 2023 Insurance MCR Improved to 78.5%, bringing year-to-date MCR to 80.8%, and Insurance revenue grew 12% compared to Q3 2022 Company reports Q3 2023 Net Loss of $41.5 million and Adjusted EBITDA loss of $5.1 million Revised full-year 2023 guidance now …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 6, 2023 - 21:05 GMT

Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 2024 – – Senti Bio eligible to receive up to $156 million in milestones and royalties – SOUTH SAN FRANCISCO, Calif., Nov. …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 6, 2023 - 21:05 GMT

Veeco Reports Third Quarter 2023 Financial Results

Third Quarter 2023 Highlights: Revenue of $177.4 million, compared with $171.9 million in the same period last year GAAP net income of $24.6 million, or $0.42 per diluted share, compared with $15.0 million, or $0.27 per diluted share in the same period …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Skyward Specialty Insurance Group Reports Third Quarter 2023 Results

HOUSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today reported third quarter 2023 net income of $21.7 million, or $0.57 per diluted share, compared to a net loss of $2 …

Distribution channels: Business & Economy, Insurance Industry ...

Published on November 6, 2023 - 21:05 GMT

Magnite to Participate in Upcoming Financial Conferences

NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate in the following financial conferences: Stephens Annual …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

Global Water Resources CEO, Ron Fleming, Featured on Premier Financial News Platform, Schwab Network

PHOENIX, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, announced its president and CEO, Ron Fleming, was a featured guest today on the popular Morning Trade Live, the flagship …

Distribution channels: Energy Industry ...

Published on November 6, 2023 - 21:05 GMT

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2023. Business highlights from the third quarter and subsequent weeks included the …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results

WARSAW, Ind., Nov. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third …

Distribution channels:

Published on November 6, 2023 - 21:05 GMT

EverCommerce Announces Third Quarter 2023 Financial Results

DENVER, Nov. 06, 2023 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended September 30, 2023. Third Quarter …

Distribution channels:

Published on November 6, 2023 - 21:04 GMT

November 6 - State Coordinated Elections Ballots Returned: November 6, 2023

State of Colorado Department of State 1700 Broadway Suite 550 Denver, CO 80290 Jena Griswold Secretary of State Chris Beall Deputy Secretary of State News Release State of Colorado Department of State 1700 Broadway Suite 550 Denver, CO 80290 Jena Griswold …

Distribution channels:

Published on November 6, 2023 - 21:03 GMT

TaskUs Announces Fiscal Third Quarter 2023 Results

NEW BRAUNFELS, Texas, Nov. 06, 2023 (GLOBE NEWSWIRE) -- TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and next-generation customer experience to the world’s most innovative companies, today announced its results for the …

Distribution channels: Business & Economy, IT Industry ...

Published on November 6, 2023 - 21:03 GMT

Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update

-- Completed Successful End-of-Phase 2 Meeting with FDA for VAX-24; Topline Phase 3 Data in Adults Expected in 2025 -- -- Received FDA Clearance of VAX-31 Adult IND Application; Phase 1/2 Study Initiation Expected This Quarter and Topline Data Expected …

Distribution channels: